SABS SAB Biotherapeutics, Inc.
Nasdaq · SEC CIK 1833214 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 113 since 2021-10-05, latest 2026-09-18 16:15
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Moin Andrew | Dir | — | — |
| Kropotova Alexandra | Chief MEDICAL Off | — | — |
| Sessa Capital GP, LLC | Dir | — | — |
Transactions 41
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-18 16:15 | 2026-09-17 | SABS | Kropotova Alexandra | Chief MEDICAL Off | F - Tax | — | -473 | 41.9K | -1% | — | |
| 2026-06-26 17:20 | 2026-06-25 | SABS | Kropotova Alexandra | Chief MEDICAL Off | F - Tax | — | -988 | 42.3K | -2% | — | |
| 2026-03-25 | 2026-03-24 | SABS | Kropotova Alexandra | Chief MEDICAL Off | F - Tax | — | -988 | 43.3K | -2% | — | |
| 2025-12-12 | 2025-12-11 | SABS | Kropotova Alexandra | Chief MEDICAL Off | F - Tax | — | -988 | 44.3K | -2% | — | |
| DI | 2025-10-01 | 2025-09-29 | SABS | Moin Andrew | Dir | M - OptEx | $1.75 | +1.74M | 2.20M | +380% | +$3.04M |
| D | 2025-10-01 | 2025-09-29 | SABS | Sessa Capital GP, LLC | Dir | M - OptEx | $1.75 | +1.74M | 2.20M | +380% | +$3.04M |
| 2025-09-22 | 2025-09-19 | SABS | Kropotova Alexandra | Chief MEDICAL Off | F - Tax | — | -1,977 | 45.3K | -4% | — | |
| 2025-04-01 | 2025-03-27 | SABS | Kropotova Alexandra | Chief MEDICAL Off | F - Tax | — | -1,179 | 47.2K | -2% | — | |
| 2024-12-31 | 2024-12-18 | SABS | Kropotova Alexandra | Chief MEDICAL Off | F - Tax | — | -9,072 | 48.4K | -16% | — | |
| 2023-12-08 | 2023-12-07 | SABS | Sullivan Eddie Joe | CEO, Dir | P - Purchase | $0.88 | +1,740 | 5.23M | +0.0% | +$1,531 | |
| 2023-11-30 | 2023-11-30 | SABS | King Michael | CFO | P - Purchase | $0.9 | +5,000 | 5,000 | New | +$4,500 | |
| 2023-11-30 | 2023-11-29 | SABS | Reich Samuel J | Executive COB, Dir | P - Purchase | $0.89 | +11.0K | 219.0K | +5% | +$9,790 | |
| DI | 2023-11-28 | 2023-11-24 | SABS | Moin Andrew | Dir | M - OptEx | — | +4.58M | 4.58M | New | — |
| DI | 2023-11-28 | 2023-11-24 | SABS | Ellias Helen K. | Dir | M - OptEx | — | +2.86M | 2.86M | New | — |
| D | 2023-11-28 | 2023-11-24 | SABS | Sessa Capital IM GP, LLC | Dir | M - OptEx | — | +4.58M | 4.58M | New | — |
| 2023-03-16 | 2023-03-14 | SABS | Kropotova Alexandra | Chief Medical Off | A - Grant | — | +275.0K | 275.0K | New | — | |
| DI | 2022-12-09 | 2022-12-07 | SABS | HAMILTON CHRISTINE E | Dir, 10% | A - Grant | $1.21 | +83.0K | 3.11M | +3% | +$100.4K |
| D | 2022-12-09 | 2022-12-07 | SABS | Spragens Jeffrey G | Dir | A - Grant | $1.21 | +83.0K | 395.0K | +27% | +$100.4K |
| D | 2022-12-09 | 2022-12-07 | SABS | Link David Charles | Dir | A - Grant | $1.21 | +41.5K | 57.3K | +262% | +$50.2K |
| 2022-09-14 | 2022-09-13 | SABS | HAMILTON CHRISTINE E | Dir, 10% | P - Purchase | $0.73 | +10.0K | 4.99M | +0.2% | +$7,300 | |
| 2022-09-08 | 2022-09-07 | SABS | Sullivan Eddie Joe | CEO, Dir, 10% | P - Purchase | $0.74 | +14.0K | 5.23M | +0.3% | +$10.4K | |
| 2022-06-07 | 2022-06-06 | SABS | Kropotova Alexandra | Chief Medical Off | A - Grant | $0.00 | +300.0K | 300.0K | New | $0 | |
| 2022-05-23 | 2022-05-20 | SABS | Reich Samuel J | Executive COB, Dir | J - Other | $0.00 | +207.0K | 208.0K | +20,700% | $0 | |
| I | 2022-05-23 | 2022-05-20 | SABS | Reich Samuel J | Executive COB, Dir | J - Other | $0.00 | -2.50M | 547.7K | -82% | $0 |
| 2022-05-23 | 2022-05-20 | SABS | Spragens Jeffrey G | Dir | J - Other | $0.00 | +299.0K | 312.0K | +2,300% | $0 | |
| MI | 2021-11-16 | 2021-09-28+ | SABS | Beyer Russell P | CFO | A - Grant | $9.07 | +293 | 278 | New | +$2,657 |
| 2021-11-16 | 2021-10-18 | SABS | Beyer Russell P | CFO | A - Grant | $10.10 | +2,475 | 2,475 | New | +$25.0K | |
| I | 2021-11-16 | 2021-10-26 | SABS | Beyer Russell P | CFO | S - Sale | $7.90 | -278 | 0 | -100% | -$2,196 |
| D | 2021-10-26 | 2021-10-22 | SABS | Link David Charles | Dir | A - Grant | — | +15.8K | 15.8K | New | — |
| DI | 2021-10-26 | 2021-10-22 | SABS | Link David Charles | Dir | A - Grant | — | +12.1K | 12.1K | New | — |
| D | 2021-10-26 | 2021-10-22 | SABS | Finnegan Frederick | Chief Business Off | A - Grant | — | +38.6K | 38.6K | New | — |
| DMI | 2021-10-26 | 2021-10-12+ | SABS | Hamilton Edward D. | 10% | A - Grant | $10.09 | +5.10M | 25.0K | New | +$51.43M |
| DM | 2021-10-26 | 2021-10-01+ | SABS | Hamilton Edward D. | 10% | A - Grant | $10.10 | +5.00M | 5,092 | New | +$50.53M |
| DM | 2021-10-26 | 2021-10-07+ | SABS | Sullivan Eddie Joe | CEO, Dir, 10% | A - Grant | $10.07 | +5.22M | 2,800 | New | +$52.53M |
| DM | 2021-10-26 | 2021-10-19+ | SABS | Luke Thomas Charles | Chief Medical Off | A - Grant | $10.10 | +6,418 | 5,428 | New | +$64.8K |
| DMI | 2021-10-26 | 2021-10-01+ | SABS | HAMILTON CHRISTINE E | Dir, 10% | A - Grant | $10.09 | +5.03M | 4.97M | New | +$50.74M |
| DM | 2021-10-26 | 2021-10-12+ | SABS | HAMILTON CHRISTINE E | Dir, 10% | A - Grant | $10.09 | +5.07M | 5.05M | New | +$51.20M |
| 2021-10-15 | 2021-10-13 | SABS | Katz Ilan | Dir, 10% | P - Purchase | $10.11 | +500 | 1,500 | +50% | +$5,055 | |
| 2021-10-15 | 2021-10-14 | SABS | Reich Samuel J | CEO, CFO, Dir, 10% | P - Purchase | $10.11 | +1,000 | 1,000 | New | +$10.1K | |
| 2021-10-05 | 2021-10-01 | SABS | Spragens Jeffrey G | Dir | P - Purchase | $10.07 | +13.0K | 13.0K | New | +$130.9K | |
| 2021-10-05 | 2021-10-01 | SABS | Katz Ilan | Dir, 10% | P - Purchase | $10.09 | +1,000 | 1,000 | New | +$10.1K |
Purchase Sale Sale after option exercise All abbreviations